Compare LXRX & MBVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LXRX | MBVI |
|---|---|---|
| Founded | 1995 | 2025 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 465.2M | 433.0M |
| IPO Year | 2000 | 2025 |
| Metric | LXRX | MBVI |
|---|---|---|
| Price | $1.31 | $10.09 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $3.23 | N/A |
| AVG Volume (30 Days) | ★ 4.1M | 139.4K |
| Earning Date | 03-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $70,864,000.00 | N/A |
| Revenue This Year | $56.61 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1255.21 | N/A |
| 52 Week Low | $0.28 | $9.99 |
| 52 Week High | $1.83 | $10.50 |
| Indicator | LXRX | MBVI |
|---|---|---|
| Relative Strength Index (RSI) | 49.20 | 47.37 |
| Support Level | $1.17 | $10.13 |
| Resistance Level | $1.39 | $10.18 |
| Average True Range (ATR) | 0.14 | 0.02 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 33.61 | 0.11 |
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.
M3-Brigade Acquisition VI Corp is a newly incorporated blank check company.